Putignano P - Search Results

1

Midnight salivary cortisol versus urinary free and midnight serum cortisol as screening tests for Cushing's syndrome.

Putignano P, Toja P, Dubini A, Pecori Giraldi F, Corsello SM, Cavagnini F. Putignano P, et al. J Clin Endocrinol Metab. 2003 Sep;88(9):4153-7. doi: 10.1210/jc.2003-030312. J Clin Endocrinol Metab. 2003. PMID: 12970280 Clinical Trial.

2

The desmopressin test in the differential diagnosis between Cushing's disease and pseudo-Cushing states.

Moro M, Putignano P, Losa M, Invitti C, Maraschini C, Cavagnini F. Moro M, et al. Among authors: putignano p. J Clin Endocrinol Metab. 2000 Oct;85(10):3569-74. doi: 10.1210/jcem.85.10.6862. J Clin Endocrinol Metab. 2000. PMID: 11061503 Clinical Trial.

3

Salivary cortisol measurement in normal-weight, obese and anorexic women: comparison with plasma cortisol.

Putignano P, Dubini A, Toja P, Invitti C, Bonfanti S, Redaelli G, Zappulli D, Cavagnini F. Putignano P, et al. Eur J Endocrinol. 2001 Aug;145(2):165-71. doi: 10.1530/eje.0.1450165. Eur J Endocrinol. 2001. PMID: 11454512

4

Screening for Cushing's syndrome in obese women with and without polycystic ovary syndrome.

Putignano P, Bertolini M, Losa M, Cavagnini F. Putignano P, et al. J Endocrinol Invest. 2003 Jun;26(6):539-44. doi: 10.1007/BF03345217. J Endocrinol Invest. 2003. PMID: 12952368

5

Urinary free cortisol is unrelated to physiological changes in urine volume in healthy women.

Putignano P, Dubini A, Cavagnini F. Putignano P, et al. Clin Chem. 2000 Jun;46(6 Pt 1):879. Clin Chem. 2000. PMID: 10839786 No abstract available.

6

Cushing's syndrome.

Pecori Giraldi F, Putignano P, Cavagnini F. Pecori Giraldi F, et al. Among authors: putignano p. Lancet. 2001 Jun 30;357(9274):2138. doi: 10.1016/s0140-6736(00)05212-0. Lancet. 2001. PMID: 11448004 No abstract available.

7

Effect of small doses of dexamethasone on plasma leptin levels in normal and obese subjects: a dose-response study.

Putignano P, Brunani A, Dubini A, Bertolini M, Pasquali R, Cavagnini F; "Study Group on Obesity" of the Italian Society of Endocrinology. Putignano P, et al. J Endocrinol Invest. 2003 Feb;26(2):111-6. doi: 10.1007/BF03345137. J Endocrinol Invest. 2003. PMID: 12739736 Clinical Trial.

8

Tissue-specific dysregulation of 11beta-hydroxysteroid dehydrogenase type 1 and pathogenesis of the metabolic syndrome.

Putignano P, Pecori Giraldi F, Cavagnini F. Putignano P, et al. J Endocrinol Invest. 2004 Nov;27(10):969-74. doi: 10.1007/BF03347544. J Endocrinol Invest. 2004. PMID: 15762049 Review.

9

Effect of acute and chronic administration of tamoxifen on GH response to GHRH and on IGF-I serum levels in women with breast cancer.

Corsello SM, Rota CA, Putignano P, Della Casa S, Barnabei A, Migneco MG, Vangeli V, Barini A, Mandalà M, Barone C, Barbarino A. Corsello SM, et al. Among authors: putignano p. Eur J Endocrinol. 1998 Sep;139(3):309-13. doi: 10.1530/eje.0.1390309. Eur J Endocrinol. 1998. PMID: 9758441 Clinical Trial.

10

Alterations in serum protein levels in patients with Cushing's syndrome before and after successful treatment.

Putignano P, Kaltsas GA, Korbonits M, Jenkins PJ, Monson JP, Besser GM, Grossman AB. Putignano P, et al. J Clin Endocrinol Metab. 2000 Sep;85(9):3309-12. doi: 10.1210/jcem.85.9.6833. J Clin Endocrinol Metab. 2000. PMID: 10999826 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

40 results

Search Page

Filters